Hormonal Regulation of Immune Responses

免疫反应的激素调节

基本信息

  • 批准号:
    RGPIN-2021-04156
  • 负责人:
  • 金额:
    $ 2.33万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2022
  • 资助国家:
    加拿大
  • 起止时间:
    2022-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

The CRTh2-PGD2 pathway mediates many homeostatic aspects of cellular function including chemotaxis, cytokine expression and mucous production. CRTh2 is expressed by a number of cell types, though its regulation has been studied mainly in T lymphocytes. Expression of CRTh2 by CD4+ T lymphocytes is a marker of a fully differentiated Th2 cells producing the characteristic type 2 cytokines that mediate physiologic responses such as immune tolerance during pregnancy, fat biogenesis and tissue repair. My laboratory has been studying CRTh2 and its role in Th2 cell biology since 2005. Using whole genome maps of regulatory elements in human cells, we developed an approach to study the molecular regulation of CRTh2 in a cell type-specific manner. Analysis of these regions show that in T cells CRTh2 may be regulated by the glucocorticoid (GC) cortisol and the sex hormone estrogen. Supporting this, our functional data suggest Th2 cell response to GC is enhanced in the presence of estrogen and may involve induction of reactive oxygen species (ROS). It is our hypothesis that hormones regulate T cell fate and their role in immunity by influencing CRTh2 and Th2 cell function in a sex-specific manner. This study is designed to determine how Th2 cells are regulated by cortisol and whether there are differences based on estrogen exposure and/or biological sex. To do this, we will examine hormonal control of CRTh2 expression and signaling, Th2 cell function, ROS production and cellular metabolism and development of a specialized tissue-residing Th2 subset. We will characterize responses of both female and male Th2 cells, to identify general and sex-specific effects. Using Th2 cells as an experimental paradigm will reveal previously unappreciated physiologic responses contributing to CRTh2-mediated signaling and allow us to study how cellular control of ROS regulates their function. Significance: Our findings will be of broad biologic interest as they will be relevant to the many other cell types and systems expressing CRTh2 and utilizing ROS-mediated signaling for cellular regulation. Our study will be carried out primarily by graduate and undergraduate students and so will also facilitate my goal of training the next generation of scientists and instilling in them the importance of incorporating biological sex when studying immune responses.
CRTh 2-PGD 2通路介导细胞功能的许多稳态方面,包括趋化性、细胞因子表达和粘液产生。CRTh 2由许多细胞类型表达,尽管其调节主要在T淋巴细胞中进行了研究。通过CD 4 + T淋巴细胞表达CRTh 2是完全分化的Th 2细胞的标志物,其产生介导生理应答如妊娠期间的免疫耐受、脂肪生物生成和组织修复的特征性2型细胞因子。自2005年以来,我的实验室一直在研究CRTh 2及其在Th 2细胞生物学中的作用。利用人类细胞中调控元件的全基因组图谱,我们开发了一种以细胞类型特异性方式研究CRTh 2分子调控的方法。对这些区域的分析表明,在T细胞中,CRTh 2可能受到糖皮质激素(GC)皮质醇和性激素雌激素的调节。支持这一点,我们的功能数据表明,在雌激素的存在下,Th 2细胞对GC的反应增强,并可能涉及诱导活性氧(ROS)。我们的假设是,激素通过以性别特异性方式影响CRTh 2和Th 2细胞功能来调节T细胞命运及其在免疫中的作用。本研究旨在确定皮质醇如何调节Th 2细胞,以及是否存在基于雌激素暴露和/或生物性别的差异。为此,我们将研究CRTh 2表达和信号传导的激素控制,Th 2细胞功能,ROS产生和细胞代谢以及专门的组织驻留Th 2亚群的发展。我们将描述女性和男性Th 2细胞的反应,以确定一般和性别特异性的影响。使用Th 2细胞作为实验范例将揭示以前未被认识到的生理反应,有助于CRTh 2介导的信号传导,并使我们能够研究细胞如何控制ROS调节其功能。重要性:我们的发现将具有广泛的生物学意义,因为它们将与表达CRTh 2并利用ROS介导的信号传导进行细胞调节的许多其他细胞类型和系统相关。我们的研究将主要由研究生和本科生进行,因此也将促进我培养下一代科学家的目标,并向他们灌输在研究免疫反应时纳入生物性别的重要性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cameron, LisaElizabeth其他文献

Cameron, LisaElizabeth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cameron, LisaElizabeth', 18)}}的其他基金

Hormonal Regulation of Immune Responses
免疫反应的激素调节
  • 批准号:
    RGPIN-2021-04156
  • 财政年份:
    2021
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Discovery Grants Program - Individual

相似海外基金

B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Research Grant
Regulation of coronavirus cross-reactivity and immune durability for pan-coronavirus vaccine development
泛冠状病毒疫苗开发中冠状病毒交叉反应性和免疫耐久性的调节
  • 批准号:
    478959
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Operating Grants
Vascular regulation of immune system ageing
免疫系统衰老的血管调节
  • 批准号:
    MC_UU_00036/6
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Intramural
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
  • 批准号:
    10625948
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
Innate immune regulation of lung inflammation through mitochondrial dynamics
通过线粒体动力学调节肺部炎症的先天免疫
  • 批准号:
    10659953
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
Regulation of natural killer cell-mediated immune response in breast cancer
自然杀伤细胞介导的乳腺癌免疫反应的调节
  • 批准号:
    494926
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Operating Grants
Immune (dys-)regulation by the PD-1/PD-L checkpoint pathway in chronic liver disease
慢性肝病中 PD-1/PD-L 检查点通路的免疫(失调)调节
  • 批准号:
    MR/X009904/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Research Grant
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Studentship
Receptor Usage and Regulation of the Immune Response in HSV Infection
HSV 感染中受体的使用和免疫反应的调节
  • 批准号:
    10738934
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
Innate immune regulation by TSLP controls Strongyloides venezuelensis infection
TSLP 的先天免疫调节控制委内瑞拉类圆线虫感染
  • 批准号:
    23K06521
  • 财政年份:
    2023
  • 资助金额:
    $ 2.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了